Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study
Publication date: September 2026 Source: Thrombosis Research, Volume 265 Author(s): Ariela Hoxha, Giovanni Gobbo, Elena Campello, Luca Spiezia, Paolo Scarinzi, Ezio Zanon, Stéfan Zuily, Walter Ageno, Paolo Simioni
Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study. // Thrombosis Research. – URL: https://www.sciencedirect.com/science/article/pii/S0049384826002240?dgcid=rss_sd_all
Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study. Thrombosis Research. https://www.sciencedirect.com/science/article/pii/S0049384826002240?dgcid=rss_sd_all
“Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study.” Thrombosis Research.
@article{article101661,
title = {Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study},
journal = {Thrombosis Research},
url = {https://www.sciencedirect.com/science/article/pii/S0049384826002240?dgcid=rss_sd_all}
}